Kuemmel S, Fasching PA, Schmid P, Harbeck N, et al. ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study. Ann Surg Oncol 2026 Mar 12. doi: 10.1245/s10434-026-19310.
PMID: 41817930